Drugmaker pulls 17K antifungal pills in Class I recall : com

Scynexis is recalling 17,376 cartons of Brexafemme (ibrexafungerp) tablets due to a potential cross-contamination risk.

Related Keywords

New Jersey , United States , , Drugmaker , Recall , Rexafemme , Brexafungerp , Tablets , Ulvovaginal , Candidiasis , Cross Contamination , Risk ,